9:00 AM - 9:12 AM

[28K-am01S] Development of gold nanorod-chondroitin sulfate complexes for cancer-targeted photothermal therapy

○Toshie Tanaka¹, Kohei Sano¹, Mayumi Miki¹, Mamia Munemura¹, Masayuki Munekane¹, Toshihide Yamasaki¹, Takahiro Mukai¹ (1. Kobe Pharm. Univ.)

9:12 AM - 9:24 AM

[28K-am02S] Upregulating the anti-tumor activity of mesenchymal stem cells exhibiting bystander effects by modifying the cell surface with anti-cancer agents

○Yukiya Takayama¹, Kosuke Kusamori¹, Mari Tsujimura¹, Makiya Nishikawa¹ (1. Fac. Pharm. Sci., Tokyo Univ. Sci.)

9:24 AM - 9:36 AM

[28K-am03S] Induction of antigen-specific immunity by pH-sensitive β-glucan-modified liposomes and their antitumor effects

○Shin Yanagihara¹, Eiji Yuba¹, Atsushi Harada¹ (1. Grad. Sch. Eng., Osaka Pref. Univ.)

9:36 AM - 9:48 AM

[28K-am04S] Combination cancer treatment with liposomes encapsulating panobinostat and vincristine

○Seishiro Morimoto¹, Momoe Katagiri¹, Naoto Oku^1,2, Tomohiro Asai¹ (1. Grad. Sch. Pharm. Sci. Univ of Shizuoka., 2. Teikyo Univ.)

9:48 AM - 10:00 AM

[28K-am05S] Mechanism of RISET therapy ; Intra-spleen localization of anti-inflammatory drug-loaded nanoparticles

○Mizuki Doi¹, Takara Ohto¹, Hiroki Tanaka¹, Naoya Miura¹, Yu Sakurai¹, Hidetaka Akita¹ (1. Graduate School of Pharmaceutical Scieces, Chiba University)

10:00 AM - 10:12 AM

[28K-am06S] Development of active drug delivery system
with anticancer drug-encapsulated liposome loaded microbubble
and ultrasound for cancer therapy

○Yuno Suzuki¹, Daiki Omata¹, Lisa Munakata¹, Tadamitsu Shima¹, Saori Kageyama¹, Fumiko Hagiwara¹, Kazuo Maruyama¹, Ryo Suzuki¹ (1. Fac. Pharma-Sci., Teikyo Univ.)

10:12 AM - 10:24 AM

[28K-am07S] Elucidation of structure-function relationship of Takumi-shaped DNA unit constituting DNA hydrogel

○Jian Jin¹, Kosuke Kusamori¹, Makiya Nishikawa¹ (1. Fac. Pharm. Sci., Tokyo Univ. Sci.)

10:24 AM - 10:36 AM

[28K-am08S] Discovery of a new tumor delivery mechanism for Abraxane^®, an albumin-bound paclitaxel

○Maichi Hama¹, Yu Ishima¹, Hidenori Ando¹, Taro Shimizu¹, Tatsuhiro Ishida¹ (1. Institute of Biomedical Sciences, Tokushima University)

10:36 AM - 10:48 AM

[28K-am09S] Chemical properties and anti-tumor activities of synthetic high-density lipoproteins

○Atsushi Kanayama¹, Kento Ohkawachi¹, Taro Shimizu¹, Akira Shigenaga¹, Akira Otaka¹, Tatsuhiro Ishida¹, Keiichiro Okuhira¹ (1. Institute of Biomedical Sciences, Tokushima University)

10:48 AM - 11:00 AM

[28K-am10S] Determining the appropriate B cell subset to use for cellular vaccine

○Yoshino Kawaguchi¹, Mizuki Awata¹, Yuna Shimazaki¹, Chihiro Yoshioka¹, Taro Shimizu¹, Hidenori Ando¹, Yu Ishima¹, Tatsuhiro Ishida¹ (1. Institute of Biomedical Sciences, Tokushima University)

11:00 AM - 11:12 AM

[28K-am11] Creation of Type II receptor-selective TNF antagonist to overcome tumor immune escape mechanisms

○Tetsuya Nomura¹, Shunsuke Inoue¹, Yoko Tada¹, Masaki Inoue^2,3, Naoya Koizumi¹, Haruhiko Kamada^3,4,5, Shinichi Tsunoda^2,3,5, Naoki Utoguchi¹ (1. Showa Pharm. Univ., 2. Fac. Pharm. Sci., Kobe-Gakuin Univ., 3. NIBIO, 4. Grad. Sch. Pharm. Sci., Osaka Univ., 5. MEI Center, Osaka Univ.)

11:12 AM - 11:24 AM

[28K-am12S] Suppression of off-target delivery of nano-drugs and augmentation of therapeutic effect of nanomedicine by Intralipid®

○Rayhanul Islam¹, Waliul Islam², Hiroshi Maeda^2,3, Jun Fang¹ (1. Grad. Sch. Pharm. Sci., Sojo Univ., 2. Grad. Sch. Med. Sci., Kumamoto Univ., 3. BioDynamics Res. Foundation)

11:24 AM - 11:36 AM

[28K-am13S] Elucidation of the cellular uptake mechanism of nanostructured nucleic acids by macrophage scavenger receptor 1

○Keisuke Umemura¹, Shozo Ohtsuki¹, Takao Inoue², Yuki Takahashi¹, Yoshinobu Takakura¹, Makiya Nishikawa^1,3 (1. Grad. Sch. Pharm. Sci., Kyoto Univ., 2. National Institute of Health Sciences, 3. Faculty of Pharm. Sci., Tokyo University of Science)

Session information

[28K-am] がん治療DDS